Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Norges Bank
Oslo,
Norway
| $1.54B | -$64.6M | 13 | 0.87% | Reduced |
|
| 27 |
BlackRock Group
London,
United Kingdom
| $1.43B | +$30.9M | 25 | 0.89% | Increased |
|
| 28 |
UBS AM
Chicago,
Illinois
| $1.43B | +$122M | 18 | 1.52% | Increased |
|
| 29 |
Bank of America
Charlotte,
North Carolina
| $1.32B | -$183M | 34 | 0.49% | Reduced |
|
| 30 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1.29B | -$20.3M | 36 | 0.92% | Reduced |
|
| 31 |
Geode Capital Management
Boston,
Massachusetts
| $1.26B | +$67.2M | 35 | 0.85% | Increased |
|
| 32 |
Sands Capital Management
Arlington,
Virginia
| $1.2B | +$86.1M | 1 | 3.14% | Increased |
|
| 33 |
BlackRock Advisors
Wilmington,
Delaware
| $1.16B | +$45.3M | 30 | 1.14% | Increased |
|
| 34 |
Ameriprise
Minneapolis,
Minnesota
| $1.15B | +$311M | 23 | 0.69% | Increased |
|
| 35 |
Glenview Capital Management
New York
| $1.15B | +$122M | 1 | 7.53% | Increased |
|
| 36 |
TIAA CREF Investment Management
New York
| $1.15B | -$104M | 26 | 0.83% | Reduced |
|
| 37 |
Brown Brothers Harriman & Co
New York
| $1.06B | -$1B | 6 | 4.51% | Reduced |
|
| 38 |
Dimensional Fund Advisors
Austin,
Texas
| $964M | -$4.59M | 17 | 0.72% | Reduced |
|
| 39 |
Neuberger Berman Group
New York
| $957M | -$210M | 11 | 0.97% | Reduced |
|
| 40 |
BNP Paribas Financial Markets
Paris,
France
| $948M | +$723M | 20 | 0.74% | Increased |
|
| 41 |
AllianceBernstein
Nashville,
Tennessee
| $923M | -$220M | 27 | 0.8% | Reduced |
|
| 42 |
Brown Advisory
Baltimore,
Maryland
| $874M | +$21.3M | 8 | 2.78% | Increased |
|
| 43 |
Winslow Capital Management
Minneapolis,
Minnesota
| $866M | -$37.9M | 1 | 2.71% | Reduced |
|
| 44 |
1832 Asset Management
Toronto,
Ontario, Canada
| $865M | +$63.7M | 8 | 2.97% | Increased |
|
| 45 |
OrbiMed
New York
| $865M | -$53.4M | 9 | 10.63% | Reduced |
|
| 46 |
Managed Account Advisors
Jersey City,
New Jersey
| $855M | +$7.37M | 19 | 1.11% | Increased |
|
| 47 |
Janus Henderson Investors US
Denver,
Colorado
| $840M | +$97.1M | 11 | 0.78% | Increased |
|
| 48 |
ClearBridge Investments
New York
| $814M | -$19.3M | 9 | 0.97% | Reduced |
|
| 49 |
UBS
Zurich,
Switzerland
| $721M | +$22.1M | 36 | 0.64% | Increased |
|
| 50 |
D.E. Shaw & Co
New York
| $703M | +$103M | 18 | 1% | Increased |
|